SQI Diagnostics Inc is a Canada based diagnostics company. It is engaged in developing and commercializing proprietary technologies and products for multiplexing diagnostics. The company develops multiplexed tests and automated systems for customers to measure biomarkers in blood or other common sample types. It offers solutions to the testing needs of three markets namely, Pharmaceutical and Biotechnology drug development, Human diagnostic testing, and Animal health diagnostic testing. Its multiplexed products and services include detecting and quantifying proteins, antibodies, and DNA. The company principally operates in the geographic regions of North America and Europe, of which the majority of the revenue is derived from Europe.